系统性硬化症胃窦血管扩张症与抗RNA聚合酶III抗体及ANA阴性相关
该队列研究纳入2004至2018年在斯坦福接受胃镜的225例系统性硬化症(SSc)患者,其中19例(8.4%)存在胃窦血管扩张症(GAVE)。多因素分析显示抗RNA聚合酶III抗体阳性(OR 4.57)和ANA阴性(OR 3.75)与GAVE显著相关。
要点
- SSc患者中GAVE患病率为8.4%(19/225)。
- 抗RNA聚合酶III抗体阳性与GAVE独立相关(OR 4.57)。
- ANA阴性(<1:80)与GAVE独立相关(OR 3.75)。
核心结论
- 抗RNA聚合酶III抗体阳性和ANA阴性与SSc患者发生GAVE显著相关。
研究设计与样本
- 2004至2018年斯坦福单中心SSc患者队列研究,纳入接受胃镜(EGD)者225例,比较GAVE组与非GAVE组的临床特征。
主要发现
- 225例接受EGD的SSc患者中19例(8.4%)有GAVE。
- GAVE组更常见硬皮病肾危象(21% vs 3%;p<0.01)。
- GAVE组更常见抗RNA聚合酶III抗体阳性(71% vs 19%;p<0.01)。
- GAVE组更常见核仁型ANA(33% vs 11%;p=0.04)和ANA阴性(33% vs 11%;p=0.02)。
- 多因素分析中抗RNA聚合酶III抗体阳性(OR 4.57;95%CI 1.57-13.23;p<0.01)和ANA阴性(OR 3.75;95%CI 1.21-11.62;p=0.02)与GAVE独立相关。
关键数值与推荐
- 抗RNA聚合酶III抗体阳性与GAVE的OR为4.57(95%CI 1.57-13.23;p<0.01)。
- ANA阴性(免疫荧光<1:80)与GAVE的OR为3.75(95%CI 1.21-11.62;p=0.02)。
临床怎么用
- 对SSc患者,尤其抗RNA聚合酶III抗体阳性或ANA阴性者,应警惕GAVE可能。
- 是否应对上述自身抗体谱患者进行筛查性内镜尚需进一步研究确定。
局限性
- 单中心回顾性队列研究,仅纳入接受EGD的SSc患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Gastric antral vascular ectasia (GAVE) is a vascular manifestation of systemic sclerosis (SSc) that can lead to iron deficiency anemia or acute gastrointestinal (GI) bleeding. We aimed to identify clinical features associated with GAVE. METHODS: We performed a cohort study of SSc patients who were seen at Stanford between 2004 and 2018 and had undergone esophagogastroduodenoscopy (EGD). We compared the clinical features of those with and without GAVE, and multivariable logistic regression was performed to identify clinical correlates with GAVE. RESULTS: A total of 225 patients with SSc who underwent EGD were included in this study and 19 (8.4%) had GAVE. Those with GAVE were more likely to have scleroderma renal crisis (SRC) (21% vs 3%; p < 0.01), positive anti-RNA polymerase III antibody (71% vs 19%; p < 0.01), nucleolar pattern of anti-nuclear antibody (ANA) (33% vs 11%; p=0.04), and negative ANA (<1:80 by immunofluorescence) (33% vs 11%; p=0.02). On multivariate analysis with multiple imputation, anti-RNA polymerase III positivity (OR 4.57; 95% CI (1.57 - 13.23), p < 0.01) and ANA negativity (OR 3.75; 95% CI (1.21 - 11.62), p=0.02) remained significantly associated with GAVE. CONCLUSION: Positive anti-RNA polymerase III antibody and ANA negativity were significantly associated with GAVE. Further studies are necessary to determine whether patients with these autoantibody profiles should undergo screening endoscopies for GAVE.
引用
- Serling-Boyd N, Chung MP, Li S, et al. Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies. Semin Arthritis Rheum. 2020. PMID: 32906028. doi:10.1016/j.semarthrit.2020.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。